BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3739728)

  • 1. Effect of detomidine on the release and turnover of noradrenaline in rat brain.
    Virtanen R; MacDonald E; Kaisila M
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):348-54. PubMed ID: 3739728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the alpha 1- and alpha 2-adrenoceptor effects of detomidine, a novel veterinary sedative analgesic.
    Virtanen R; Nyman L
    Eur J Pharmacol; 1985 Jan; 108(2):163-9. PubMed ID: 2984021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of adenylate cyclase and protein kinase C in the alpha 2-adrenoceptor-mediated inhibition of noradrenaline and 5-hydroxytryptamine release in rat hypothalamic slices.
    Ramdine R; Galzin AM; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):386-95. PubMed ID: 2479843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evidence for the involvement of alpha-2 adrenoceptors in the sedative effect of detomidine, a novel sedative-analgesic.
    Virtanen R; Ruskoaho H; Nyman L
    J Vet Pharmacol Ther; 1985 Mar; 8(1):30-7. PubMed ID: 2859378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
    Harsing LG; Vizi ES
    J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive activity and mechanism of action of detomidine.
    Virtanen R
    J Vet Pharmacol Ther; 1986 Sep; 9(3):286-92. PubMed ID: 3761419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of 3-methoxy-4-hydroxyphenylglycol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradrenaline utilisation and presynaptic alpha 2-adrenoceptor function.
    Heal DJ; Prow MR; Buckett WR
    Br J Pharmacol; 1989 Mar; 96(3):547-56. PubMed ID: 2541844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of detomidine and xylazine on some alpha 2-adrenoceptor-mediated responses in the central and peripheral nervous systems.
    Virtanen R; MacDonald E
    Eur J Pharmacol; 1985 Sep; 115(2-3):277-84. PubMed ID: 2998825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and neurochemical effects of antipamezole, a novel alpha 2-adrenoceptor antagonist.
    Scheinin H; MacDonald E; Scheinin M
    Eur J Pharmacol; 1988 Jun; 151(1):35-42. PubMed ID: 2901363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of [3H]-amezinium from cortical noradrenergic axons: a model for the study of the alpha-autoreceptor hypothesis.
    Hedler L; Starke K; Steppeler A
    Br J Pharmacol; 1983 Apr; 78(4):645-53. PubMed ID: 6303483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of central alpha-adrenoceptors by yohimbine diastereomers.
    Hedler L; Stamm G; Weitzell R; Starke K
    Eur J Pharmacol; 1981 Mar; 70(1):43-52. PubMed ID: 6260514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular action of detomidine, a sedative and analgesic imidazole derivative with alpha-agonistic properties.
    Savola JM; Ruskoaho H; Puurunen J; Kärki NT
    Eur J Pharmacol; 1985 Nov; 118(1-2):69-76. PubMed ID: 2867913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of food intake in rats by the alpha 2-adrenoceptor agonists xylazine and detomidine.
    Majeed NH; Mohammad FK; Ayoub RS
    Pharmacol Res; 1991 May; 23(4):415-9. PubMed ID: 1678886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of free MHPG in rat cerebrospinal fluid with free and conjugated MHPG in brain tissue: effects of drugs modifying noradrenergic transmission.
    Scheinin H; MacDonald E; Scheinin M
    Eur J Pharmacol; 1986 Sep; 129(1-2):113-21. PubMed ID: 2876902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro.
    Driessen B; Reimann W; Giertz H
    Br J Pharmacol; 1993 Mar; 108(3):806-11. PubMed ID: 8467366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective blockade of brain alpha 2-autoreceptors by yohimbine: effects on motor activity and on turnover of noradrenaline and dopamine.
    Andén NE; Pauksens K; Svensson K
    J Neural Transm; 1982; 55(2):111-20. PubMed ID: 6294237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y alters monoamine turnover in the rat brain.
    Vallejo M; Carter DA; Biswas S; Lightman SL
    Neurosci Lett; 1987 Jan; 73(2):155-60. PubMed ID: 3822247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by yohimbine of the calcium-dependent evoked release of [3H]GABA in rat and mouse brain slices in vitro.
    Maurin Y; Arbilla S; Langer SZ
    Eur J Pharmacol; 1985 Apr; 111(1):37-48. PubMed ID: 2990943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of idazoxan on catecholamine systems in rat brain.
    Walter DS; Flockhart IR; Haynes MJ; Howlett DR; Lane AC; Burton R; Johnson J; Dettmar PW
    Biochem Pharmacol; 1984 Aug; 33(16):2553-7. PubMed ID: 6147143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonidine reverses baclofen-induced increases in noradrenaline turnover in rat brain.
    Sawynok J; Reid A
    Neurochem Res; 1986 May; 11(5):723-31. PubMed ID: 2873522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.